Prime Discoveries develops rapid, novel diagnostics for emerging pathogen infections with a focus on cost effective, massively scalable and easily automatable assays. Prime leverages multiple patented advanced technologies in microbial diagnostics including RT-LAMP, Rapid PCR, and mNGS (Next generation sequencing) to enable samples to result in under 1 hour with minimal lab infrastructure and technical expertise. Prime’s products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime’s assays are locally developed in the United States and can serve millions of people. Founded in NYC in 2017, Prime’s scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson. Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.
View Top Employees from Prime DiscoveriesWebsite | http://www.primediscoveries.com |
Revenue | $3 million |
Employees | 5 (3 on RocketReach) |
Founded | 2018 |
Address | 315 Madison Avenue Suite 3081, New York, New York 10017, US |
Industry | Biotechnology Research, Hospitality General, Hospitality |
SIC | SIC Code 47 Companies, SIC Code 472 Companies |
NAICS | NAICS Code 561 Companies, NAICS Code 56 Companies |
Looking for a particular Prime Discoveries employee's phone or email?
The Prime Discoveries annual revenue was $3 million in 2024.
3 people are employed at Prime Discoveries.
Prime Discoveries is based in New York, New York.
The NAICS codes for Prime Discoveries are [561, 56].
The SIC codes for Prime Discoveries are [47, 472].